Aib Group Regulatory News (AIBG)

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION INTO OR IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA, SWITZERLAND OR ANY OTHER STATE OR JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS ANNOUNCEMENT

7 November 2023

Disposal of approximately 5% of AIB Group plc

Further to his announcement on 6 November 2023, the Minister for Finance, Michael McGrath TD, announces the successful completion of the disposal of part of the Irish State's shareholding in AIB Group plc (the "Company"). The disposal was effected by way of a placing (the "Placing") of shares (the "Placing Shares") in an accelerated book building process to institutional investors.

In  summary, following settlement of the Placing which will take place on 9 November 2023:

? The shareholding of the Irish State will be reduced from 1,198.6 million ordinary shares, representing approximately 45.8% of the ordinary share capital of the Company, to 1,067.6 million ordinary shares, representing approximately 40.8 % of the ordinary share capital.

? Accordingly, the overall size of the State's shareholding will be reduced by approximately 5.0%.

? The Placing price was ?3.93 per share. As a result, the gross proceeds from the sale of the Placing Shares will be ? 514.83 million. Upon settlement, this sum will be returned to the Ireland Strategic Investment Fund pending further consideration by the Minister.

? BNP Paribas, Goldman Sachs and Morgan Stanley acted as Joint Bookrunners in connection with the Placing.

? The Minister for Finance has undertaken to the Joint Bookrunners not to sell further shares in the Company for the period of 90 calendar days following the completion of the Placing without the prior written consent of the Joint Bookrunners. While this undertaking also applies to any sales through the Minister's trading plan announced by way of Regulatory News Service on 21 December 2021, extended on 23 June 2022, 5 January 2023 and further extended on 27 June 2023, it will only do so for the period of 45 calendar days following the completion of the Placing.

? N.M. Rothschild & Sons Limited ("Rothschild & Co") is acting as independent financial adviser and William Fry LLP and Allen & Overy LLP are acting as legal counsel to the Department of Finance in connection with the sale.

Enquiries:

Brian Meenan, Press Officer, Department of Finance, +3531 6045875 or + 353 872198857

pressoffice@finance.gov.ie

Important Information

This announcement is for information purposes only and does not constitute an offer or an invitation to acquire or dispose of any securities of the Company in the United States, Canada, Australia or Japan or in any other jurisdiction in which such an offer of solicitation is unlawful. The shares sold pursuant to the Placing have not been, and will not be, registered under the United States Securities Act of 1933, as amended, or under any securities laws of any state or jurisdiction of the United States and may not be offered or sold in the United States absent registration or an exemption from registration. There was no public offering of securities in the United States.

Neither this announcement nor any copy of it may be taken, transmitted or distributed, directly

or indirectly in or into the United States of America, Australia, Canada, Japan, The Republic of South Africa, Switzerland or any other jurisdiction where to do so would constitute a violation of the relevant laws or regulations of such jurisdiction. Any failure to comply with this restriction may constitute a violation of the securities laws of any such jurisdiction.

Goldman Sachs and Morgan Stanley which are authorised by the Prudential Regulation Authority (the "PRA") and regulated by the Financial Conduct Authority (the "FCA") and the PRA in the United Kingdom and BNP Paribas which is authorised and regulated by the European Central Bank and the Autorité de contrôle prudentiel et de resolution and authorised by the Prudential Regulation Authority and is subject to regulation by the Financial Conduct Authority and limited regulation by the Prudential Regulation Authority (together the "Joint Bookrunners"), and N.M. Rothschild & Sons Limited (the "Adviser") which is authorised and regulated by the FCA in the United Kingdom, are acting on behalf of the Minister for Finance and no one else in connection with any offering of the Placing Shares and will not be responsible to any other person for providing the protections afforded to any of their respective clients or for providing advice to any other person in relation to any offering of the Placing Shares. None of the Joint Bookrunners nor the Adviser will regard any other person as its client in relation to the offering of the Placing Shares. No representation or warranty, express or implied, is or will be made as to, or in relation to, and no responsibility or liability is or will be accepted by any of the Joint Bookrunners, the Adviser or by any of their respective affiliates or agents as to or in relation to, the accuracy, completeness or sufficiency of this announcement or any other written or oral information made available to or publicly available to any interested party or its advisers in connection with the Minister for Finance, the Company, the Placing Shares, the Placing or any of the arrangements described herein, and any liability therefor is expressly disclaimed.

No Placing Shares will be available to any investor whose purchase of such Placing Shares, whether on its own account or as a fiduciary or agent for one or more investor accounts, would require regulatory consent in any jurisdiction (including, without limitation, under the UK Financial Services and Markets Act 2000 or the United States Bank Holding Company Act of 1956).

Details about the extent of BNP Paribas' regulation by the Prudential Regulation Authority are available from them on request.

BNP Paribas London Branch is registered in the UK under number FC13447. UK establishment number: BR000170. UK establishment office address: 10 Harewood Avenue, London NW1 6AA